Melexis NV

MELE: XBRU (BEL)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
?bLOCK|C^zBnLOCK|T<&s#rp

Melexis Earnings: Automotive Chip Demand Shows First Signs of Cycle Improvement

In its first-quarter update, Melexis maintained its outlook and expects second-half sales to be higher than the first half. We expect second-half sales to be up 10% sequentially to around EUR 450 million, with any sharper recovery likely happening in 2027.

Sponsor Center